A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

NCT05800665 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Prostate Cancer
Metastatic Prostate Cancer

Interventions

DRUG: RO7656594

Sponsor

Genentech, Inc.